PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1622412-7	1992	Furthermore, Ro/SS-A antibodies were associated with a high incidence of side effects to D-penicillamine only in the Greeks.	Penicillamine	89-104	tripartite motif containing 21	Homo sapiens	13-20	
3266995-7	1988	D-penicillamine, given in the majority of patients in both groups, produced adverse reactions in 72% of the anti-Ro(SSA) positive patients, but only in 27% of the negative ones.	Penicillamine	0-15	tripartite motif containing 21	Homo sapiens	116-119	
3266995-8	1988	Thus, anti-Ro(SSA) antibodies seem to characterize a distinct group of RA patients who are almost exclusively female, express more activated B-cell function, have a high prevalence of Sjogren"s features and commonly develop side effects to D-penicillamine.	Penicillamine	240-255	tripartite motif containing 21	Homo sapiens	14-17	
6608925-0	1984	Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance.	Penicillamine	129-144	tripartite motif containing 21	Homo sapiens	94-97	
1827158-0	1991	D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factors.	Penicillamine	0-15	tripartite motif containing 21	Homo sapiens	78-81	
1827158-3	1991	The clinical picture in both groups was similar, but the group with D-penicillamine toxicity was characterized by a high incidence of anti-Ro(SSA) antibodies (p less than 0.01) or circulating cryoglobulins (p less than 0.001).	Penicillamine	68-83	tripartite motif containing 21	Homo sapiens	142-145